ÀÇ»çȸ¼Ò°³
ȸ Ģ
°øÁö»çÇ×
ÀÓ¿øÁø¼Ò°³
Àλ縻
ÀÓ¿øÁø¾È³»
Çмú´ëȸ
»çÀüµî·Ï
Çмú´ëȸ ÀÚ·á½Ç
¼¼¹Ì³ª ¾È³»
ȸ¿ø°Ô½ÃÆÇ
ÀÚ·á½Ç
°Ô½ÃÆÇ »è°¨ÁÙÀ̱â
ȸ Ģ
°øÁö»çÇ×
Total 283
¹øÈ£
Á¦ ¸ñ
±Û¾´ÀÌ
³¯Â¥
Á¶È¸
°øÁö
2024³â °æ³²³»°úÀÇ»çȸ Ãß°èÇмú´ëȸ ¾È³»
Ãѹ«ÀÌÁö¿µ
2024-07-29
286
°øÁö
2024³â °æ³²³»°úÀÇ»çȸ Ãá°èÇмú´ëȸ ¾È³»
Ãѹ«ÀÌ»ç
2024-02-13
728
148
Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ÇöȲ(9¿ù4ÀÏ¿ÀÈÄ4½Ã±îÁö)
±è¼º¿í
2014-09-04
765
147
Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ¸í´Ü(9¿ù3ÀÏÇÑ)
±è¼º¿í
2014-09-03
770
146
2014 Ãß°èÇмú µî·Ï ¹æ¹ý
ÃÖ°í°ü¸®ÀÚ
2014-09-03
771
145
Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ¸í´Ü(9¿ù2ÀÏÇÑ)
±è¼º¿í
2014-09-02
790
144
2014³â Ãß°èÇмú´ëȸ »çÀüµî·Ï ¸í´Ü(8¿ù 31ÀÏ ÇÑ)
±è¼º¿í
2014-08-31
786
143
SGLT-2 inhibitor°è ¾àÁ¦ÀÇ ±Þ¿©±âÁØ ½Å¼³ ¹× Exenatide ÁÖ»çÁ¦ ¡¦
ÃÖºÀ±â
2014-08-27
908
142
ÇØ¿ÜÀ¯ÀÔ °ü·Ã È«¿ª¹ß»ý ´ëÀÀ¹æ¾È-³»°ú À¯ÀÇ»çÇ× Á¤¸®
ÃÖºÀ±â
2014-08-27
899
141
°øÈÞÀÏ ÁøÂû·á °¡»ê½Ã ´ëü°øÈÞÀÏ Æ÷ÇÔ¿©ºÎ Àû¿ë ¾È³» ÇùÁ¶¿äû
ÃÖºÀ±â
2014-08-27
990
140
2014 Ãß°èÇмú´ëȸ »çÀüµî·ÏÀÚ ¸í´Ü(8¿ù 26ÀÏÇÑ)
±è¼º¿í
2014-08-26
787
139
2014³â Ãß°èÇмú´ëȸ µî·Ï ¹× ȸºñ ³³ºÎ ¹æ¹ý
ÃÖºÀ±â
2014-08-19
929
138
¸¸¼ºÁúȯ ÀûÁ¤¼º Æò°¡ ±âÁØÀÇ º¯°æ - 2014³â 7¿ùºÎÅÍ
ÃÖºÀ±â
2014-07-29
902
137
½ÉÆò¿ø¿¡¼ À§ ´ëÀå ³»½Ã°æ ÀÏȸ¿ë »ý°Ë °âÀÚ ¼³¹® Á¶»ç°Ç
ÃÖºÀ±â
2014-06-16
1254
136
Á¦19ȸ ´ëÇÑÀ§Àå³»½Ã°æÇÐȸ ÆòÀÇ¿øȸ ÀÚ·á
ÃÖºÀ±â
2014-03-13
1121
135
2014³â ÃÑȸ ¹× Ãá°èÇмú´ëȸ ¾È³»
ÃÖºÀ±â
2014-03-04
848
134
ÀÓ»óÃÊÀ½ÆÄ ÀÎÁõÀÇ ÁøÇà »çÇ×
ÃÖºÀ±â
2014-02-17
1156
1
2
3
4
5
6
7
8
9
10
Á¦¸ñ
³»¿ë
Á¦¸ñ+³»¿ë
ȸ¿ø¾ÆÀ̵ð
ȸ¿ø¾ÆÀ̵ð(ÄÚ)
±Û¾´ÀÌ
±Û¾´ÀÌ(ÄÚ)
and
or